Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03663179 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03663179: Completed NA study, sponsored by University of Pennsylvania.
NCT03663179 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03663179, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will test the effects of transcranial magnetic stimulation (TMS) on clinical measures of ADHD symptoms.
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
- DEVICE Sham Transcranial Magnetic Stimulation (Sham TMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03663179
The ClinicalTrials.gov registry entry for NCT03663179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT03663179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03663179 about?
NCT03663179 is a clinical study titled "Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)". This study will test the effects of transcranial magnetic stimulation (TMS) on clinical measures of ADHD symptoms.
What is the current status of trial NCT03663179?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03663179?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE), Sham Transcranial Magnetic Stimulation (Sham TMS) (DEVICE).
Who is sponsoring clinical trial NCT03663179?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.